Company Filing History:
Years Active: 2009
Title: Cornelia Kruse-Müller: Innovator in Immunological Determination
Introduction
Cornelia Kruse-Müller is a notable inventor based in Edewecht, Germany. She has made significant contributions to the field of immunology, particularly in the determination of specific antibodies. Her innovative approach has led to the development of a patented method that enhances the accuracy of immunological tests.
Latest Patents
Cornelia holds a patent for the invention titled "Determination of a specific immunoglobulin using multiple antigens." This invention concerns a method for the immunological determination of a specific antibody in a sample liquid. The method involves incubating the sample liquid in the presence of a solid phase with two antigens directed against the antibody to be determined. One antigen carries at least one marker group, while the second antigen is either bound to the solid phase or is in a form capable of binding to it. The antibody is detected by determining the marker group in the solid phase or in the liquid phase. Notably, at least one of the two antigens contains several epitope regions that react with the antibody to be determined. Cornelia has 1 patent to her name.
Career Highlights
Cornelia Kruse-Müller is associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. Her work at Roche has allowed her to apply her innovative ideas in a practical setting, contributing to advancements in diagnostic technologies.
Collaborations
Cornelia has collaborated with several talented individuals in her field, including Ursula-Henrike Wienhues and Eva Höss. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Cornelia Kruse-Müller is a pioneering inventor whose work in immunological determination has made a significant impact in the field of diagnostics. Her patented method showcases her commitment to advancing medical technology and improving patient outcomes.